12 results on '"J. Welzel"'
Search Results
2. Implementation of a dermatoscopy curriculum during residency at Augsburg University Hospital in Germany.
- Author
-
Schuh S, Schiele S, Thamm J, Kranz S, Welzel J, and Blum A
- Subjects
- Humans, Dermoscopy, Curriculum, Germany, Hospitals, Internship and Residency
- Abstract
Background and Objectives: To date, there is no structured program for dermatoscopy training during residency in Germany. Whether and how much dermatoscopy training is acquired is left to the initiative of each resident, although dermatoscopy is one of the core competencies of dermatological training and daily practice. The aim of the study was to establish a structured dermatoscopy curriculum during residency at the University Hospital Augsburg., Patients and Methods: An online platform with dermatoscopy modules was created, accessible regardless of time and place. Practical skills were acquired under the personal guidance of a dermatoscopy expert. Participants were tested on their level of knowledge before and after completing the modules. Test scores on management decisions and correct dermatoscopic diagnosis were analyzed., Results: Results of 28 participants showed improvements in management decisions from pre- to posttest (74.0% vs. 89.4%) and in dermatoscopic accuracy (65.0% vs. 85.6%). Pre- vs. posttest differences in test score (7.05/10 vs. 8.94/10 points) and correct diagnosis were significant (p < 0.001)., Conclusions: The dermatoscopy curriculum increases the number of correct management decisions and dermatoscopy diagnoses. This will result in more skin cancers being detected, and fewer benign lesions being excised. The curriculum can be offered to other dermatology training centers and medical professionals., (© 2023 The Authors. Journal der Deutschen Dermatologischen Gesellschaft published by John Wiley & Sons Ltd on behalf of Deutsche Dermatologische Gesellschaft.)
- Published
- 2023
- Full Text
- View/download PDF
3. Status quo and perspectives of dermatology hospitals in Germany: spectra of health care and staff situation.
- Author
-
Augustin M, Girbig G, Hertl M, Elsner P, Welzel J, Honak L, Hischke S, and Biedermann T
- Subjects
- Delivery of Health Care, Female, Germany, Hospitals, Humans, Dermatology, Physicians
- Abstract
Background: Inpatient care in Germany has been subject to change since the introduction of the DRG-based payment system. There have been no publications on important differentiating factors such as the spectrum of care and the staffing situation in dermatology., Methods: Health care analysis of 115 dermatology hospitals in October 2019 using a structured survey questionnaire., Results: On average, the spectrum of care included 31.0 % general dermatology, 33.6 % surgical dermatology, 15.6 % oncology, and 10.1 % allergology. The clinics had an average of 14 full-time positions and 3 part-time positions (university clinics: 23/5, non-university clinics: 9/2). The mean nationwide proportion of women in the physician teams showed the following distribution: postgraduate physicians 73.3 %, senior physicians 53.0 %, directors 20.0 %. The applicant situation of senior physicians and specialists was assessed as predominantly poor, that of residents as predominantly good. Worse applicant situations were present in non-university hospitals and in rural areas. The satisfaction of the medical directors with the current conditions of inpatient care showed a variable assessment independent of university hospital and non-university hospital status. However, the threat to inpatient care was predominantly assessed as low (71.6 %)., Conclusions: The overall situation of inpatient dermatological care can be classified as predominantly good. In addition, the majority of dermatology clinics provide a wide range of care with regard to the variety of indications. The general conditions, which in some cases are rated as inadequate, require further measures., (© 2021 The Authors | © Deutsche Dermatologische Gesellschaft (DDG). Published by John Wiley & Sons Ltd.)
- Published
- 2021
- Full Text
- View/download PDF
4. Inpatient care for skin diseases in Germany: multi-source analysis on the current and future health care needs.
- Author
-
Augustin M, Girbig G, Kis A, Bechara FG, Hertl M, Hischke S, Kaufmann R, Löffler H, Müller CSL, Simon JC, Strömer K, Welzel J, Wetzig T, Elsner P, Augustin J, Löser C, and Biedermann T
- Subjects
- Delivery of Health Care, Germany epidemiology, Humans, Inpatients, Dermatology, Prurigo, Skin Diseases epidemiology, Skin Diseases therapy
- Abstract
Background: In Germany, skin diseases are mainly treated in the 115 dermatological hospitals., Methods: Health care and health economic analysis of dermatological inpatient care and prediction of future care needs based on primary and secondary data., Results: Outpatient and inpatient care for dermatologic treatment indications is predominantly provided by dermatology specialists. Inpatient treatment was provided for 833,491 cases in 2018, corresponding to 4.21 % of all inpatient cases (19,808,687). Most common treatment cases were: epithelial skin cancer (total 87,386, of which dermatology clinics 52,608), followed by melanoma (23,917/17,774), psoriasis (19,291/13,352), erysipelas (73,337/11,260), other dermatitis (12,671/10,842), atopic dermatitis (AD) (11,421/9,734), and herpes zoster (26,249/9,652). With an average length of stay of 5.69 days, dermatology hospitals were in the bottom third. The proportion of inpatient indications cared for in dermatology hospitals was highest for prurigo (95.2 %), pemphigus (94.9 %), parapsoriasis (94.6 %), pemphigoid (90.3 %), eczema other than AD (85.6 %), and AD (85.2 %). While the total number of inpatient treatment cases in Germany has increased by an average of 17.5 % between 2000 and 2018, this is the case for 26.6 % of skin diseases and over 150 % for individual ones. The projection of current to future inpatient care suggests a continued high demand for inpatient care by dermatology hospitals., Conclusion: Inpatient dermatological care will continue to be an indispensable component of qualified, socially necessary care in Germany., (© 2021 The Authors | © Deutsche Dermatologische Gesellschaft (DDG). Published by John Wiley & Sons Ltd.)
- Published
- 2021
- Full Text
- View/download PDF
5. Structures and performance characteristics of dermatology hospitals in Germany. Current status and long-term development.
- Author
-
Girbig G, Biedermann T, Hertl M, Elsner P, Welzel J, Hischke S, Honak L, and Augustin M
- Subjects
- Cross-Sectional Studies, Diagnosis-Related Groups, Germany epidemiology, Hospitals, University, Humans, Dermatology
- Abstract
Background: The objective of the study was to characterize the performance of German dermatology hospitals., Methods: A structured survey questionnaire was sent out to all dermatology hospitals in October 2019 as part of a cross-sectional analysis based on health care research., Results: Of the 115 hospitals, 95 (82.6 %) responded, including 34 (35.8 %) university hospitals (UC) and 61 (64.2 %) non-university hospitals (NUC), of which 78 % were urban (43 % UC, 57 % NUC) and 22 % rural (10 % UC, 90 % NUC). The dermatology departments comprised an average of 45 inpatient and 11 day-care beds (UC: 52/13, NUC: 40/9). An average of 2,302 inpatients were cared for in 2018 (UC: 2,874, NUC: 1,983), and the case mix index was 0.76 (UC: 0.74, NUC: 0.77, overall range: 0.40-0.96). Mean length of stay was 5.5 days for UC, relevantly lower than 2013 (5.9 days) and 2011 (7.1 days) data, and also significantly lower for NUC at 5.9 (2018) versus 5.1 days (2013)., Conclusions: German dermatology hospitals continue to have a high volume of inpatient care, with a comparison of the last six years again showing a compression with shorter length of stay and higher occupancy density. Dermatological hospitals represent an essential pillar of dermatological care., (© 2021 The Authors | © Deutsche Dermatologische Gesellschaft (DDG). Published by John Wiley & Sons Ltd.)
- Published
- 2021
- Full Text
- View/download PDF
6. Patterns of care and follow-up care of patients with uveal melanoma in German-speaking countries: a multinational survey of the German Dermatologic Cooperative Oncology Group (DeCOG).
- Author
-
Steeb T, Wessely A, Alter M, Bayerl C, Bender A, Bruning G, Dabrowski E, Debus D, Devereux N, Dippel E, Drexler K, Dücker P, Dummer R, Emmert S, Elsner P, Enk A, Gebhardt C, Gesierich A, Goebeler M, Goerdt S, Goetze S, Gutzmer R, Haferkamp S, Hansel G, Hassel JC, Heinzerling L, Kähler KC, Kaume KM, Krapf W, Kreuzberg N, Lehmann P, Livingstone E, Löffler H, Loquai C, Mauch C, Mangana J, Meier F, Meissner M, Moritz RKC, Maul LV, Müller V, Mohr P, Navarini A, Van Nguyen A, Pfeiffer C, Pföhler C, Posch C, Richtig E, Rompel R, Sachse MM, Sauder S, Schadendorf D, Schatton K, Schulze HJ, Schultz E, Schilling B, Schmuth M, Simon JC, Streit M, Terheyden P, Thiem A, Tüting T, Welzel J, Weyandt G, Wesselmann U, Wollina U, Ziemer M, Zimmer L, Zutt M, Berking C, Schlaak M, and Heppt MV
- Subjects
- Austria epidemiology, Cross-Sectional Studies, Follow-Up Studies, Germany epidemiology, Health Services Needs and Demand statistics & numerical data, Humans, Mass Screening methods, Mass Screening statistics & numerical data, Melanoma epidemiology, Melanoma pathology, Neoplasm Metastasis, Neoplasm Recurrence, Local epidemiology, Population Surveillance methods, Referral and Consultation standards, Referral and Consultation statistics & numerical data, Skin Neoplasms epidemiology, Skin Neoplasms pathology, Skin Neoplasms therapy, Surveys and Questionnaires, Switzerland epidemiology, Uveal Neoplasms epidemiology, Uveal Neoplasms pathology, Aftercare methods, Aftercare statistics & numerical data, Melanoma therapy, Monitoring, Physiologic methods, Monitoring, Physiologic statistics & numerical data, Practice Patterns, Physicians' statistics & numerical data, Uveal Neoplasms therapy
- Abstract
Purpose: Uveal melanoma (UM) is an orphan cancer of high unmet medical need. Current patterns of care and surveillance remain unclear as they are situated in an interdisciplinary setting., Methods: A questionnaire addressing the patterns of care and surveillance in the management of patients with uveal melanoma was distributed to 70 skin cancer centers in Austria, Germany and Switzerland. Frequency distributions of responses for each item of the questionnaire were calculated., Results: 44 of 70 (62.9%) skin cancer centers completed the questionnaire. Thirty-nine hospitals were located in Germany (88.6%), three in Switzerland (6.8%) and two in Austria (4.5%). The majority (68.2%) represented university hospitals. Most patients with metastatic disease were treated in certified skin cancer centers (70.7%, 29/41). Besides, the majority of patients with UM were referred to the respective skin cancer center by ophthalmologists (87.2%, 34/39). Treatment and organization of follow-up of patients varied across the different centers. 35.1% (14/37) of the centers stated to not perform any screening measures., Conclusion: Treatment patterns of patients with uveal melanoma in Germany, Austria and Switzerland remain extremely heterogeneous. A guideline for the treatment and surveillance is urgently needed.
- Published
- 2021
- Full Text
- View/download PDF
7. SARS-CoV-2 infections in melanoma patients treated with PD-1 inhibitors: A survey of the German ADOREG melanoma registry.
- Author
-
Moritz RKC, Gutzmer R, Zimmer L, Meier F, Ahmed MS, Sell S, Schlaak M, Kapp F, Sachse MM, Haferkamp S, Welzel J, Kähler KC, and Weichenthal M
- Subjects
- Adult, Aged, Aged, 80 and over, COVID-19 diagnosis, COVID-19 immunology, COVID-19 therapy, Female, Germany epidemiology, Humans, Immune Checkpoint Inhibitors adverse effects, Male, Melanoma epidemiology, Melanoma immunology, Middle Aged, Prognosis, Registries, Risk Assessment, Risk Factors, Skin Neoplasms epidemiology, Skin Neoplasms immunology, COVID-19 epidemiology, Immune Checkpoint Inhibitors therapeutic use, Melanoma drug therapy, Programmed Cell Death 1 Receptor antagonists & inhibitors, Skin Neoplasms drug therapy
- Abstract
Competing Interests: Conflict of interest statement The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Katharina C Kähler reports being a consultant to Roche, BMS, MSD, Pierre Fabre and receiving travel grants and speaker fees from Roche, BMS, MSD, Amgen, Pierre Fabre and Philogen. Ralf Gutzmer reports receiving honoraria from Roche, BMS, MSD, Novartis, Amgen, Merck Serono, Almirall Hermal, SUN, Sanofi, Pierre Fabre and being a consultant or advisor for BMS, Roche, Novartis, Almirall Hermal, MSD, Amgen, SUN, Sanofi, Pierre Fabre, merck serono, Bayer, Pfizer. RG reports receiving research funding from Novartis, Pfizer, Johnson & Johnson, Amgen, Merck Serono, Sun Pharma, Sanofi and travel accommodations and expenses from Roche, BMS, Sun Pharma, Merck Serono and Pierre Fabre. Julia Welzel reports receiving honoraria from MSD. Lisa Zimmer: LZ reports receiving honoraria from Roche, Bristol-Myers Squibb, Merck Sharp & Dohme, Novartis, and Pierre Fabre; research funding from Novartis; advisory board roles for Bristol-Myers Squibb, Novartis, Pierre Fabre, Sun Pharma, Sanofi, and Merck Sharp & Dohme; and travel support from Bristol-Myers Squibb, Pierre Fabre, Sanofi, Amgen, Novartis, and Sun Pharma. Max Schlaak reports receiving honoraria and participation in advisory boards of Bristol-Myers Squibb, Novartis, MSD, Roche, Pierre Fabre, Kyowa Kirin, and Sanofi-Genzyme. MS received travel accommodation and expenses by Novartis, Pierre Fabre, and Sun Pharma. Sebastian Haferkamp reports grants from BMS and personal fees from BMS, Novartis, Pierre Fabre and MSD. Rose KC Moritz reports receiving honoraria from BMS, Pfizer, Merck Serono, Kyowa Kirin and participation in advisory boards by Takeda, Novartis, MSD, BMS, Roche, and Merck Serono. RKCM reports receiving travel accommodations and expenses by BMS, Novartis, Kyowa Kirin, and Ricordati. All other authors declare no conflict of interest.
- Published
- 2021
- Full Text
- View/download PDF
8. S3 guideline for actinic keratosis and cutaneous squamous cell carcinoma (cSCC) - short version, part 2: epidemiology, surgical and systemic treatment of cSCC, follow-up, prevention and occupational disease.
- Author
-
Leiter U, Heppt MV, Steeb T, Amaral T, Bauer A, Becker JC, Breitbart E, Breuninger H, Diepgen T, Dirschka T, Eigentler T, Flaig M, Follmann M, Fritz K, Greinert R, Gutzmer R, Hillen U, Ihrler S, John SM, Kölbl O, Kraywinkel K, Löser C, Nashan D, Noor S, Nothacker M, Pfannenberg C, Salavastru C, Schmitz L, Stockfleth E, Szeimies RM, Ulrich C, Welzel J, Wermker K, Garbe C, and Berking C
- Subjects
- Aged, Carcinoma, Squamous Cell therapy, Disease Progression, Female, Germany epidemiology, Humans, Keratosis, Actinic therapy, Male, Occupational Diseases prevention & control, Skin Neoplasms therapy, Carcinoma, Squamous Cell epidemiology, Keratosis, Actinic epidemiology, Skin Neoplasms epidemiology
- Abstract
Actinic keratoses (AKs) are common lesions in light-skinned individuals that can potentially progress to cutaneous squamous cell carcinoma (cSCC). Both conditions may be associated with significant morbidity and constitute a major disease burden, especially among the elderly. To establish an evidence-based framework for clinical decision making, the guidelines for actinic keratosis and cutaneous squamous cell carcinoma were developed using the highest level of methodology (S3) according to regulations issued by the Association of Scientific Medical Societies in Germany (AWMF). The guidelines are aimed at dermatologists, general practitioners, ENT specialists, surgeons, oncologists, radiologists and radiation oncologists in hospitals and office-based settings as well as other medical specialties involved in the diagnosis and treatment of patients with AKs and cSCC. The guidelines are also aimed at affected patients, their relatives, policy makers and insurance funds. In the second part, we will address aspects relating to epidemiology, etiology, surgical and systemic treatment of cSCC, follow-up and disease prevention, and discuss AKs and cSCC in the context of occupational disease regulations., (© 2020 The Authors. Journal der Deutschen Dermatologischen Gesellschaft published by John Wiley & Sons Ltd on behalf of Deutsche Dermatologische Gesellschaft.)
- Published
- 2020
- Full Text
- View/download PDF
9. S3 guideline for actinic keratosis and cutaneous squamous cell carcinoma - short version, part 1: diagnosis, interventions for actinic keratoses, care structures and quality-of-care indicators.
- Author
-
Heppt MV, Leiter U, Steeb T, Amaral T, Bauer A, Becker JC, Breitbart E, Breuninger H, Diepgen T, Dirschka T, Eigentler T, Flaig M, Follmann M, Fritz K, Greinert R, Gutzmer R, Hillen U, Ihrler S, John SM, Kölbl O, Kraywinkel K, Löser C, Nashan D, Noor S, Nothacker M, Pfannenberg C, Salavastru C, Schmitz L, Stockfleth E, Szeimies RM, Ulrich C, Welzel J, Wermker K, Berking C, and Garbe C
- Subjects
- Carcinoma, Squamous Cell therapy, Disease Progression, Germany, Humans, Indicators and Reagents, Keratosis, Actinic therapy, Skin Neoplasms therapy, Carcinoma, Squamous Cell diagnosis, Keratosis, Actinic diagnosis, Quality of Health Care, Skin Neoplasms diagnosis
- Abstract
Actinic keratoses (AK) are common lesions in light-skinned individuals that can potentially progress to cutaneous squamous cell carcinoma (cSCC). Both conditions may be associated with significant morbidity and constitute a major disease burden, especially among the elderly. To establish an evidence-based framework for clinical decision making, the guideline "actinic keratosis and cutaneous squamous cell carcinoma" was developed using the highest level of methodology (S3) according to regulations issued by the Association of Scientific Medical Societies in Germany (AWMF). The guideline is aimed at dermatologists, general practitioners, ENT specialists, surgeons, oncologists, radiologists and radiation oncologists in hospitals and office-based settings as well as other medical specialties involved in the diagnosis and treatment of patients with AK and cSCC. The guideline is also aimed at affected patients, their relatives, policy makers and insurance funds. In the first part, we will address aspects relating to diagnosis, interventions for AK, care structures and quality-of-care indicators., (© 2020 The Authors. Journal der Deutschen Dermatologischen Gesellschaft published by John Wiley & Sons Ltd on behalf of Deutsche Dermatologische Gesellschaft.)
- Published
- 2020
- Full Text
- View/download PDF
10. Motor, cognitive and mobility deficits in 1000 geriatric patients: protocol of a quantitative observational study before and after routine clinical geriatric treatment - the ComOn-study.
- Author
-
Geritz J, Maetzold S, Steffen M, Pilotto A, Corrà MF, Moscovich M, Rizzetti MC, Borroni B, Padovani A, Alpes A, Bang C, Barcellos I, Baron R, Bartsch T, Becktepe JS, Berg D, Bergeest LM, Bergmann P, Bouça-Machado R, Drey M, Elshehabi M, Farahmandi S, Ferreira JJ, Franke A, Friederich A, Geisler C, Hüllemann P, Gierthmühlen J, Granert O, Heinzel S, Heller MK, Hobert MA, Hofmann M, Jemlich B, Kerkmann L, Knüpfer S, Krause K, Kress M, Krupp S, Kudelka J, Kuhlenbäumer G, Kurth R, Leypoldt F, Maetzler C, Maia LF, Moewius A, Neumann P, Niemann K, Ortlieb CT, Paschen S, Pham MH, Puehler T, Radloff F, Riedel C, Rogalski M, Sablowsky S, Schanz EM, Schebesta L, Schicketmüller A, Studt S, Thieves M, Tönges L, Ullrich S, Urban PP, Vila-Chã N, Wiegard A, Warmerdam E, Warnecke T, Weiss M, Welzel J, Hansen C, and Maetzler W
- Subjects
- Aged, Brazil, Cognition, Fear, Geriatric Assessment, Germany, Humans, Italy, Portugal, Prospective Studies, Quality of Life, Accidental Falls, Activities of Daily Living
- Abstract
Background: Motor and cognitive deficits and consequently mobility problems are common in geriatric patients. The currently available methods for diagnosis and for the evaluation of treatment in this vulnerable cohort are limited. The aims of the ComOn (COgnitive and Motor interactions in the Older populatioN) study are (i) to define quantitative markers with clinical relevance for motor and cognitive deficits, (ii) to investigate the interaction between both motor and cognitive deficits and (iii) to assess health status as well as treatment outcome of 1000 geriatric inpatients in hospitals of Kiel (Germany), Brescia (Italy), Porto (Portugal), Curitiba (Brazil) and Bochum (Germany)., Methods: This is a prospective, explorative observational multi-center study. In addition to the comprehensive geriatric assessment, quantitative measures of reduced mobility and motor and cognitive deficits are performed before and after a two week's inpatient stay. Components of the assessment are mobile technology-based assessments of gait, balance and transfer performance, neuropsychological tests, frailty, sarcopenia, autonomic dysfunction and sensation, and questionnaires to assess behavioral deficits, activities of daily living, quality of life, fear of falling and dysphagia. Structural MRI and an unsupervised 24/7 home assessment of mobility are performed in a subgroup of participants. The study will also investigate the minimal clinically relevant change of the investigated parameters., Discussion: This study will help form a better understanding of symptoms and their complex interactions and treatment effects in a large geriatric cohort.
- Published
- 2020
- Full Text
- View/download PDF
11. S2k Guidelines for Cutaneous Basal Cell Carcinoma - Part 2: Treatment, Prevention and Follow-up.
- Author
-
Lang BM, Balermpas P, Bauer A, Blum A, Brölsch GF, Dirschka T, Follmann M, Frank J, Frerich B, Fritz K, Hauschild A, Heindl LM, Howaldt HP, Ihrler S, Kakkassery V, Klumpp B, Krause-Bergmann A, Löser C, Meissner M, Sachse MM, Schlaak M, Schön MP, Tischendorf L, Tronnier M, Vordermark D, Welzel J, Weichenthal M, Wiegand S, Kaufmann R, and Grabbe S
- Subjects
- Aged, Aged, 80 and over, Carcinoma, Basal Cell epidemiology, Carcinoma, Basal Cell prevention & control, Carcinoma, Basal Cell therapy, Disease Management, Follow-Up Studies, Germany epidemiology, Humans, Incidence, Middle Aged, Neoplasm Recurrence, Local epidemiology, Neoplasm Recurrence, Local pathology, Neoplasm Recurrence, Local prevention & control, Practice Guidelines as Topic, Risk Assessment, Skin Neoplasms epidemiology, Skin Neoplasms therapy, Carcinoma, Basal Cell pathology, Managed Care Programs standards, Quality of Health Care standards, Skin Neoplasms pathology
- Abstract
Basal cell carcinoma (BCC) is the most common malignant tumor among fair-skinned individuals, and its incidence had been steadily rising in the past decades. In order to maintain the highest quality of patient care possible, the German S2k guidelines were updated following a systematic literature search and with the participation of all professional societies and associations involved in the management of the disease. Part 2 addresses issues such as proper risk stratification, the various therapeutic approaches, and prevention as well as follow-up of patients with basal cell carcinoma., (© 2019 The Authors | Journal compilation © Blackwell Verlag GmbH, Berlin.)
- Published
- 2019
- Full Text
- View/download PDF
12. [Phlebology in German departments of dermatology. An analysis on behalf of the German Society of Phlebology].
- Author
-
Reich-Schupke S, Alm J, Altmeyer P, Bachter D, Bayerl C, Beissert S, Bieber T, Böhmer J, Dill D, Dippel E, Dücker P, Effendy I, El Gammal S, Elsner P, Enk A, Feldmann-Böddeker I, Frank H, Gehring W, Gieler U, Goebeler M, Görge T, Gollnick H, Grabbe S, Gross G, Gudat W, Happ A, Herbst R, Hermes B, Hoff NP, John SM, Jungelhülsing M, Jünger M, Kaatz M, Kapp A, Kaufmann R, Klode J, Knaber K, König A, Krieg T, Kohl P, Kowalzick L, Lehmann P, Löffler H, Maschke J, Marsch W, Mechtel D, Mohr P, Moll I, Müller M, Nashan D, Ockenfels HM, Peter RU, Pillekamp H, Rompel R, Ruzicka T, Salfeld K, Sander C, Schaller J, Scharffetter-Kochanek K, Schuler G, Schulze HJ, Schwarz T, Splieth B, Stege H, Stolz W, Strölin A, Tran H, Tronnier M, Ulrich J, Vogt T, Wagner G, Welzel J, Willgeroth T, Wollina U, Zillikens D, Zouboulis CC, Zuberbier T, Zutt M, and Stücker M
- Subjects
- Germany epidemiology, Humans, Professional Competence statistics & numerical data, Skin Diseases, Vascular epidemiology, Surveys and Questionnaires, Venous Insufficiency epidemiology, Dermatology statistics & numerical data, Hospital Departments statistics & numerical data, Practice Patterns, Physicians' statistics & numerical data, Skin Diseases, Vascular diagnosis, Skin Diseases, Vascular therapy, Venous Insufficiency diagnosis, Venous Insufficiency therapy
- Abstract
Background: Phlebologic diseases have become extremely common and have major socio-economic impact. However, the percentage of dermatologists working in phlebology appears to be decreasing according to the data of the German Society of Phlebology (DGP)., Methods: To investigate the reasons for this development, we--on behalf of the DGP--sent a questionnaire to 120 German Departments of Dermatology in autumn 2012., Results: In 76 returned questionnaires, the number of physicians with additional fellowship training in phlebology averaged 1.5; the average number of those who fulfill the criteria for training fellows in phlebology was 0.9. In 71.1 % of the departments there was a phlebologist. A special phlebologic outpatient clinic existed in 73.7 % of the departments. Sonography with Doppler (89.5 %) and duplex (86.8 %) was used as the most frequent diagnostic tool. For therapy, compression (94.7 %), sclerotherapy (liquid 78.9 %, foam 63.2 %, catheter 18.4 %), endoluminal thermic procedures (radio wave 28.9 %, laser 17.1 %) and surgery (especially crossectomy and stripping 67.1 %, phlebectomy of tributaries 75 %) were used. The average number of treatments was very heterogenous in the different departments., Conclusions: Phlebology definitely plays an important role in dermatology. Most departments fulfill the formal criteria for the license to conduct advanced training in phlebology. A wide spectrum of phlebological diagnostic and therapeutic procedures is available.
- Published
- 2013
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.